BWXT Medical Ltd.
Ottawa, ON · Canada
Specialization: Medical radioisotopes and radiopharmaceutical APIs
Key Differentiator
Makes both finished nuclear medicine products and radiopharmaceutical APIs at a CNSC-regulated facility in Kanata.
Core Services
Actinium-225; Germanium-68; Indium-111; Iodine-123; Strontium-82; Finished products and APIs for nuclear medicine
Capabilities
Market Intelligence
Formed in 2018 when BWX Technologies bought the Nordion Medical Isotopes division from Sotera Health. Sites in Ottawa and Vancouver with more than 300 staff. The site reports BWXT is selling the medical business to Nordic Capital and will keep a minority stake.
Website
https://www.bwxtmedical.comSimilar Companies
Ashland (Pharma)
Wilmington, DE · Polymers & Specialty Ingredients
NYSE: ASH; broad polymer portfolio enabling modified-release and ODT formulations; critical role in amorphous solid dispersion technology for poorly soluble drugs
Avantor / J.T. Baker
Radnor, PA · High-Purity Chemicals & Excipients
NYSE: AVTR; $7.3B revenue; critical supplier of high-purity process chemicals to biopharma; opened advanced Dublin distribution center (Nov 2022)
Colorcon
Harleysville, PA · Film Coatings & Colorants
World leader in film coating systems; signed $740M 10-year deal with Lotte Fine Chemical for pharma cellulose (Oct 2024); global supply + application labs network
DFE Pharma
Toronto region, ON · Lactose & Inhalation Excipients
World leader in lactose-based excipients; Canadian distribution serving growing domestic pharma manufacturing sector
Need help finding the right outsourcing partner?
Try AI NavigatorCompany information is sourced from publicly available data and may not be current. PharmoniQ does not endorse any company listed. Contact companies directly for the most up-to-date information.